^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Mantle Cell Lymphoma |
| Drug: | bendamustine (DNA replication inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Mantle cell lymphoma: Other recommended regimens...Bendamustine, bortezomib, and rituximab (category 2B)
